Filing Details
- Accession Number:
- 0000950170-25-076417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-05-22 16:48:38
- Reporting Period:
- 2025-05-20
- Filing Date:
- 2025-05-22
- Accepted Time:
- 2025-05-22 16:48:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1529655 | Charles Gary Robb | C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065 | Chief Business Officer | No | No | No | No |
Transaction Summary
| Sold: | 2,279 shares | Avg. Price: $75.85 | Total Value: $172,862.15 |
| Number of Shares After Transactions: | 11,571 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-05-20 | 2,279 | $75.85 | 16,586 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-05-20 | 1,380 | $0.00 | 15,206 | No | 4 | G | Direct | |
| Common Stock | Acquisiton | 2025-05-20 | 360 | $0.00 | 11,571 | No | 4 | G | Indirect | Custodial Account for Child |
| Common Stock | Acquisiton | 2025-05-20 | 360 | $0.00 | 11,571 | No | 4 | G | Indirect | Custodial Account for Child |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | G | Direct | |
| No | 4 | G | Indirect | Custodial Account for Child |
| No | 4 | G | Indirect | Custodial Account for Child |
Footnotes
- Includes 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024, 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024, 290 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 2, 2024 and 292 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 3, 2025. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
Billionaire Hedge Funds
